SSY Group Limited (2005) Financial History

Name: SSY Group Limited (2005) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-11

SSY Group Limited (2005) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Wan Chai, Hong Kong with about 5,472 employees. Its market capitalization is roughly HKD 7 billion. In the fiscal year ended 2025-12-31, 2005 reported HKD 4.2B in revenue and HKD 471M in net income.

SSY Group Limited, an investment holding company, researches, develops, manufactures, trades, and sells various pharmaceutical products to hospitals and distributors in the People's Republic of China and internationally.

Interactive charts & full statements →

2005 Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Revenue	HKD 4.2B	HKD 5.8B	HKD 6.5B	HKD 6.4B	—
Gross Profit	HKD 1.7B	HKD 2.9B	HKD 3.6B	HKD 3.6B	—
Operating Income (EBIT)	HKD 584M	HKD 1.3B	HKD 1.6B	HKD 1.4B	—
Net Income	HKD 471M	HKD 1.1B	HKD 1.3B	HKD 1.1B	—

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

2005 Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	(HKD 427M)	(HKD 534M)	(HKD 446M)	(HKD 388M)	—

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

2005 Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	HKD 12.8B	HKD 12.6B	HKD 12.0B	HKD 11.0B	—
Total Liabilities	HKD 5.2B	HKD 5.1B	HKD 4.7B	HKD 4.4B	—

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2005 viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

2186 · Luye Pharma Group Ltd. — $8 billion
0460 · Sihuan Pharmaceutical Holdings Group Ltd. — $8 billion
APTX · Apotex Health Corp. — $8 billion
0570 · China Traditional Chinese Medicine Holdings Co. Limited — $7 billion
2575 · Xuanzhu Biopharmaceutical Co., Ltd. — $6 billion
6185 · CanSino Biologics Inc. — $6 billion
4539 · Nippon Chemiphar Co., Ltd. — $6 billion
3613 · Beijing Tong Ren Tang Chinese Medicine Company Limited — $6 billion

← 2004 All “0-9” companies 2007 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.